Skip to main content
Log in

Staging cardiac damage in patients with aortic regurgitation

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

The impact of “downstream” pathophysiological cardiac consequences in aortic regurgitation patients were not well established. The aim of our study was to validate a staging system built for severe aortic stenosis in a large real-world cohort of aortic regurgitation (AR) patients, evaluating the prevalence of different stages of cardiac damage and assess its prognostic impact. Clinical, echocardiographic and outcome data of patients with moderate-severe AR who underwent transthoracic echocardiography between January/2014 and September/2019 were retrospectively analysed. Patients were classified according to the extent of cardiac damage: Stage 0 (no cardiac damage), Stage 1 (left ventricular damage), Stage 2 (mitral valve or left atrial damage), Stage 3 (tricuspid valve or pulmonary artery vasculature damage) and Stage 4 (right ventricular damage). The primary endpoint was all-cause mortality. A total of 571 patients (median age 73, 51% male) were enrolled: Stage 0 (14.0%), Stage 1 (21.5%), Stage 2 (49.2%), Stage 3 (12.3%) and Stage 4 (3.0%). Median follow-up time was 39.5 months (IQR 22.2 to 61.0). At the end of follow-up, cumulative death was significantly higher in more advanced disease stages (log-rank p < 0.001). On multivariable analysis, Stage 3–4 was associated with increased risk of all-cause mortality (HR 3.20; 95% CI 1.48–6.93; p = 0.003). Our study suggests that extra-valvular damage is common in patients with significant AR and that a staging system developed for aortic stenosis also provides prognostic information in these patients. This staging system may be helpful for clinical decision-making regarding the time of valvular intervention.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig.1
Fig. 2

Similar content being viewed by others

References

  1. Libby P, Bonow R, Mann D, Tomaselli G, Bhatt D, Solomon S (2021) Braunwald’s heart disease: a textbook of cardiovascular medicine, 12th edn. Elsevier. volumes cm p, Philadelphia

    Google Scholar 

  2. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2021) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 60(4):727–800. https://doi.org/10.1093/ejcts/ezab389

    Article  PubMed  Google Scholar 

  3. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F et al (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 143(5):e72–e227. https://doi.org/10.1161/CIR.0000000000000923

    Article  PubMed  Google Scholar 

  4. Yang LT, Michelena HI, Scott CG, Enriquez-Sarano M, Pislaru SV, Schaff HV et al (2019) Outcomes in chronic hemodynamically significant aortic regurgitation and limitations of current guidelines. J Am Coll Cardiol 73(14):1741–1752. https://doi.org/10.1016/j.jacc.2019.01.024

    Article  PubMed  Google Scholar 

  5. Baumgartner H, Iung B, Otto CM (2020) Timing of intervention in asymptomatic patients with valvular heart disease. Eur Heart J 41(45):4349–4356. https://doi.org/10.1093/eurheartj/ehaa485

    Article  PubMed  Google Scholar 

  6. de Meester C, Gerber BL, Vancraeynest D, Pouleur AC, Noirhomme P, Pasquet A et al (2019) Do guideline-based indications result in an outcome penalty for patients with severe aortic regurgitation? JACC Cardiovasc Imaging 12(11 Pt 1):2126–2138. https://doi.org/10.1016/j.jcmg.2018.11.022

    Article  PubMed  Google Scholar 

  7. Yang LT, Enriquez-Sarano M, Scott CG, Padang R, Maalouf JF, Pellikka PA et al (2020) Concomitant mitral regurgitation in patients with chronic aortic regurgitation. J Am Coll Cardiol 76(3):233–246. https://doi.org/10.1016/j.jacc.2020.05.051

    Article  PubMed  Google Scholar 

  8. Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA et al (2017) Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J 38(45):3351–3358. https://doi.org/10.1093/eurheartj/ehx381

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tastet L, Tribouilloy C, Marechaux S, Vollema EM, Delgado V, Salaun E et al (2019) Staging cardiac damage in patients with asymptomatic aortic valve stenosis. J Am Coll Cardiol 74(4):550–563. https://doi.org/10.1016/j.jacc.2019.04.065

    Article  PubMed  Google Scholar 

  10. Vollema EM, Amanullah MR, Ng ACT, van der Bijl P, Prevedello F, Sin YK et al (2019) Staging cardiac damage in patients with symptomatic aortic valve stenosis. J Am Coll Cardiol 74(4):538–549. https://doi.org/10.1016/j.jacc.2019.05.048

    Article  PubMed  Google Scholar 

  11. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA et al (2013) Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 14(7):611–644. https://doi.org/10.1093/ehjci/jet105

    Article  PubMed  Google Scholar 

  12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S et al (2017) Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr 30(4):372–392. https://doi.org/10.1016/j.echo.2017.02.009

    Article  PubMed  Google Scholar 

  13. Robinson S, Ring L, Augustine DX, Rekhraj S, Oxborough D, Harkness A et al (2021) The assessment of mitral valve disease: a guideline from the British Society of Echocardiography. Echo Res Pract 8(1):G87–G136. https://doi.org/10.1530/ERP-20-0034

    Article  PubMed  PubMed Central  Google Scholar 

  14. Corp. I. IBM SPSS Statistics for Windows. Version 26.0 ed2019

  15. R Core Team. (2019) R: A language and environment for statistical computing. . R Foundation for Statistical Computing

  16. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL et al (1999) Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83(6):897–902. https://doi.org/10.1016/s0002-9149(98)01064-9

    Article  CAS  PubMed  Google Scholar 

  17. d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J et al (2016) Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J 37(47):3515–3522. https://doi.org/10.1093/eurheartj/ehw229

    Article  PubMed  PubMed Central  Google Scholar 

  18. Beaudoin J, Handschumacher MD, Zeng X, Hung J, Morris EL, Levine RA et al (2013) Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle. J Am Coll Cardiol 61(17):1809–1816. https://doi.org/10.1016/j.jacc.2013.01.064

    Article  PubMed  PubMed Central  Google Scholar 

  19. Unger P, Lancellotti P, Amzulescu M, David-Cojocariu A, de Canniere D (2019) Pathophysiology and management of combined aortic and mitral regurgitation. Arch Cardiovasc Dis 112(6–7):430–440. https://doi.org/10.1016/j.acvd.2019.04.003

    Article  PubMed  Google Scholar 

  20. Myerson SG, d’Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM et al (2012) Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation 126(12):1452–1460. https://doi.org/10.1161/CIRCULATIONAHA.111.083600

    Article  PubMed  Google Scholar 

  21. Alashi A, Mentias A, Abdallah A, Feng K, Gillinov AM, Rodriguez LL et al (2018) Incremental prognostic utility of left ventricular global longitudinal strain in asymptomatic patients with significant chronic aortic regurgitation and preserved left ventricular ejection fraction. JACC Cardiovasc Imaging 11(5):673–682. https://doi.org/10.1016/j.jcmg.2017.02.016

    Article  PubMed  Google Scholar 

  22. Lee JKT, Franzone A, Lanz J, Siontis GCM, Stortecky S, Grani C et al (2018) Early detection of subclinical myocardial damage in chronic aortic regurgitation and strategies for timely treatment of asymptomatic patients. Circulation 137(2):184–196. https://doi.org/10.1161/CIRCULATIONAHA.117.029858

    Article  PubMed  Google Scholar 

  23. Alashi A, Khullar T, Mentias A, Gillinov AM, Roselli EE, Svensson LG et al (2020) Long-term outcomes after aortic valve surgery in patients with asymptomatic chronic aortic regurgitation and preserved LVEF: impact of baseline and follow-up global longitudinal strain. JACC Cardiovasc Imaging 13(1 Pt 1):12–21. https://doi.org/10.1016/j.jcmg.2018.12.021

    Article  PubMed  Google Scholar 

  24. Mosquera VX, Bouzas-Mosquera A, Gonzalez-Barbeito M, Bautista-Hernandez V, Muniz J, Alvarez-Garcia N et al (2017) Indexed left atrial size predicts all-cause and cardiovascular mortality in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 153(6):1275–1284. https://doi.org/10.1016/j.jtcvs.2017.01.054

    Article  PubMed  Google Scholar 

  25. Yang LT, Enriquez-Sarano M, Michelena HI, Nkomo VT, Scott CG, Bailey KR et al (2019) Predictors of progression in patients with stage B aortic regurgitation. J Am Coll Cardiol 74(20):2480–2492. https://doi.org/10.1016/j.jacc.2019.08.1058

    Article  PubMed  Google Scholar 

  26. Mentias A, Feng K, Alashi A, Rodriguez LL, Gillinov AM, Johnston DR et al (2016) Long-term outcomes in patients with aortic regurgitation and preserved left ventricular ejection fraction. J Am Coll Cardiol 68(20):2144–2153. https://doi.org/10.1016/j.jacc.2016.08.045

    Article  PubMed  Google Scholar 

  27. Senechal M, Bernier M, Dagenais F, Dubois M, Dubois-Senechal IN, Voisine P (2011) Usefulness of preoperative stroke volume as strong predictor of left ventricular remodeling and outcomes after aortic valve replacement in patients with severe pure aortic regurgitation. Am J Cardiol 108(7):1008–1013. https://doi.org/10.1016/j.amjcard.2011.05.035

    Article  PubMed  Google Scholar 

  28. MacHaalany J, Bertrand OF, Voisine P, O’Connor K, Bernier M, Dubois-Senechal IN et al (2014) Outcomes following surgical correction of pure aortic regurgitation in presence or absence of significant functional mitral regurgitation. Echocardiography 31(6):689–698. https://doi.org/10.1111/echo.12450

    Article  PubMed  Google Scholar 

  29. Tribouilloy C, Bohbot Y, Kubala M, Ruschitzka F, Popescu B, Wendler O et al (2022) Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. Eur Heart J. https://doi.org/10.1093/eurheartj/ehac209

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by national funds through FCT Fundação para a Ciência e Tecnologia, I.P., under the scope of the Cardiovascular R&D Center—UnIC (Grant Nos. UIDB/00051/2020 and UIDP/00051/2020).

Author information

Authors and Affiliations

Authors

Contributions

GS and FS: conceived the present idea and developed the theory. GS, PQ and MS: performed the data collection. GS, FS and AB: performed the computations. FS and AB: verified the analytical methods and performed the analytical calculations. JR, RF-C and FS: validated the echocardiograms and supervised the findings of this work. GS, PQ, MS and FS: wrote the manuscript. All authors provided critical feedback, contributed to the interpretation of the results and approved the final manuscript.

Corresponding author

Correspondence to Gualter Silva.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Ethical approval

The study protocol conforms to the ethical guidelines of the Declaration of Helsinki as reflected in a priori approval by the institution's human research committee.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silva, G., Queirós, P., Silva, M. et al. Staging cardiac damage in patients with aortic regurgitation. Int J Cardiovasc Imaging 38, 2645–2653 (2022). https://doi.org/10.1007/s10554-022-02673-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-022-02673-1

Keywords

Navigation